Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Anti-Inflammatory Autoimmune Disease Therapeutics
The 2025-2030 World Outlook for Anti-Inflammatory Autoimmune Disease Therapeutics This study covers the world outlook for anti-inflammatory autoimmune disease therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Drugs
The 2025-2030 World Outlook for Rheumatoid Arthritis Drugs This study covers the world outlook for rheumatoid arthritis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Hormone-Drug Breast Cancer Therapeutics
The 2025-2030 World Outlook for Hormone-Drug Breast Cancer Therapeutics This study covers the world outlook for hormone-drug breast cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for NASH (Non-Alcoholic Steatohepatitis) Biomarkers
The 2025-2030 World Outlook for NASH (Non-Alcoholic Steatohepatitis) Biomarkers This study covers the world outlook for NASH (non-alcoholic steatohepatitis) biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics This study covers the world outlook for chemotherapy and other multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More
-
The 2025-2030 World Outlook for Xerostomia Therapeutics
The 2025-2030 World Outlook for Xerostomia Therapeutics This study covers the world outlook for xerostomia therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Narcolepsy Therapeutics
The 2025-2030 World Outlook for Narcolepsy Therapeutics This study covers the world outlook for narcolepsy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Monoclonal Antibodies Protein Therapeutics
The 2025-2030 World Outlook for Monoclonal Antibodies Protein Therapeutics This study covers the world outlook for monoclonal antibodies protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Peptide Therapeutics
The 2025-2030 World Outlook for Peptide Therapeutics This study covers the world outlook for peptide therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Rare Disease Drugs
The 2025-2030 World Outlook for Rare Disease Drugs This study covers the world outlook for rare disease drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Peripheral Neuritis Treatments
The 2025-2030 World Outlook for Peripheral Neuritis Treatments This study covers the world outlook for peripheral neuritis treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Therapeutics
The 2025-2030 World Outlook for Liver Cancer Therapeutics This study covers the world outlook for liver cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Liver Cirrhosis Drugs
The 2025-2030 World Outlook for Liver Cirrhosis Drugs This study covers the world outlook for liver cirrhosis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Asthma Therapeutics
The 2025-2030 World Outlook for Asthma Therapeutics This study covers the world outlook for asthma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Acromegaly Treatments
The 2025-2030 World Outlook for Acromegaly Treatments This study covers the world outlook for acromegaly treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Recombinant Plasma Protein Therapeutics
The 2025-2030 World Outlook for Recombinant Plasma Protein Therapeutics This study covers the world outlook for recombinant plasma protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Kinase Inhibitor Drugs
The 2025-2030 World Outlook for Kinase Inhibitor Drugs This study covers the world outlook for kinase inhibitor drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Exosome Diagnostic and Therapeutics
The 2025-2030 World Outlook for Exosome Diagnostic and Therapeutics This study covers the world outlook for exosome diagnostic and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for HIV-1 Therapeutics
The 2025-2030 World Outlook for HIV-1 Therapeutics This study covers the world outlook for HIV-1 therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Respiratory Complications Therapeutics
The 2025-2030 World Outlook for Respiratory Complications Therapeutics This study covers the world outlook for respiratory complications therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Adult Malignant Glioma Therapeutics
The 2025-2030 World Outlook for Adult Malignant Glioma Therapeutics This study covers the world outlook for adult malignant glioma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics
The 2025-2030 World Outlook for Leukemia Chemotherapy Therapeutics This study covers the world outlook for leukemia chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Leukemia Treatments
The 2025-2030 World Outlook for Leukemia Treatments This study covers the world outlook for leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Krabbe Disease Treatments
The 2025-2030 World Outlook for Krabbe Disease Treatments This study covers the world outlook for Krabbe disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Vitiligo Therapeutics
The 2025-2030 World Outlook for Vitiligo Therapeutics This study covers the world outlook for vitiligo therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
Research Assistance
